A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α

Citations Over TimeTop 1% of 2010 papers

Abstract

Glioma growth and progression depend on a specialized subpopulation of tumour cells, termed tumour stem cells. Thus, tumour stem cells represent a critical therapeutic target, but the molecular mechanisms that regulate them are poorly understood. Hypoxia plays a key role in tumour progression and in this study we provide evidence that the hypoxic tumour microenvironment also controls tumour stem cells. We define a detailed molecular signature of tumour stem cell genes, which are overexpressed by tumour cells in vascular and perinecrotic/hypoxic niches. Mechanistically, we show that hypoxia plays a key role in the regulation of the tumour stem cell phenotype through hypoxia-inducible factor 2alpha and subsequent induction of specific tumour stem cell signature genes, including mastermind-like protein 3 (Notch pathway), nuclear factor of activated T cells 2 (calcineurin pathway) and aspartate beta-hydroxylase domain-containing protein 2. Notably, a number of these genes belong to pathways regulating the stem cell phenotype. Consistently, tumour stem cell signature genes are overexpressed in newly formed gliomas and are associated with worse clinical prognosis. We propose that tumour stem cells are maintained within a hypoxic niche, providing a functional link between the well-established role of hypoxia in stem cell and tumour biology. The identification of molecular regulators of tumour stem cells in the hypoxic niche points to specific signalling mechanisms that may be used to target the glioblastoma stem cell population.

Related Papers

• → The Early Growth Response Factor-1 Contributes to Interleukin-13 Production by Mast Cells in Response to Stem Cell Factor Stimulation(2008)9 cited
• → Measurement of Human and Murine Stem Cell Factor (c‐kit Ligand)(1992)8 cited
• → Expression of Stem Cell Factor in Feline Mast Cell Tumour(2018)4 cited
• → Mastocytosis cells bearing a c‐kit activating point mutation are characterized by hypersensitivity to stem cell factor and increased apoptosis(2000)14 cited
• Expression of c-Kit/SCF and Inhibin-alpha in Ovarian Follicles During Mouse Development.(2003)